T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer
Clinical trial NCT04611126 · TERMINATED
Trial details
- NCT number
- NCT04611126
- Sponsor
- Inge Marie Svane
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2024-03-03
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.